ACSBG1 and familial dilated cardiomyopathy: This anti-inflammatory function may potentially influence inflammation levels in cardiomyocytes affected by DCM (33).The present study constitutes the initial discovery of an association between Acsbg1 and DCM as a novel therapeutic target.